Navigation Links
Anthrax Vaccine Shows Promise in Monkeys
Date:1/20/2012

FRIDAY, Jan. 20 (HealthDay News) -- Monkeys vaccinated with an anthrax capsule vaccine were protected against lethal anthrax infection, a new study has found.

The anthrax capsule is a naturally occurring component of Bacillus anthracis, the bacterium that causes anthrax.

This is the first successful use of a non-toxin vaccine to protect monkeys from anthrax, which is regarded as one of the most serious bioterrorism threats, according to the U.S. Army scientists who conducted the study.

Bacillus anthracis produces three main components that enable it to cause harm -- lethal toxin, edema toxin and the capsule. During anthrax infection, the capsule surrounds the bacterium and protects it from destruction by the body's white blood cells.

In this study, the researchers found that the anthrax capsule vaccine induced anti-capsule antibody responses in both rabbits and monkeys. Vaccinated rabbits were not protected against anthrax spores, but many of the vaccinated monkeys did survive.

The study appears in the Jan. 20 print issue of the journal Vaccine.

Current human vaccines for anthrax are based on the protective antigen component of the anthrax toxins, but there are concerns about relying on a single antigen and about anthrax strains that may be vaccine resistant, said senior author Arthur Friedlander of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

"This is the first non-toxin anthrax vaccine shown to be protective in monkeys. In addition, this new capsule vaccine is expected to work against possible vaccine-resistant strains of anthrax, as well as in recipients whose immune systems may not respond to protective antigen alone," Friedlander said in a USAMRIID news release.

While the findings of the new study are promising, scientists note that research involving animals often fails to produce similar results in humans.

More information

The U.S. Centers for Disease Control and Prevention has more about anthrax.

-- Robert Preidt

SOURCE: U.S. Army Medical Research Institute of Infectious Diseases, news release, Jan. 12, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Poll: Hypothetical anthrax attack and antibiotics
2. Bacillus anthracis and Anthrax
3. Community storage of anthrax-preventing antibiotics should be determined by state
4. Natural killer cells could be key to anthrax defense
5. Anthrax capsule vaccine protects monkeys from lethal infection
6. Vaccine May Prevent TB in People With HIV
7. Vaccine Not Fail-Safe in Ongoing Mumps Outbreak
8. New strategy produces promising advance in cancer vaccines
9. Screens, Vaccine for HPV Less Beneficial in Older Women
10. New Technology Could Widen Reach of Vaccines
11. Texas-based consortium announces groundbreaking vaccine research program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... More than half of Americans suffering from noise-induced ... their leisure time that causes hearing loss? May 1 marks the beginning of Better ... hearing loss, as well as schedule a hearing evaluation for anyone with concerns about ...
(Date:4/28/2017)... Cary, NC (PRWEB) , ... April 28, 2017 ... ... to announce its new partnership with the Home Care Association of America (HCAOA). ... Hospice, and Private Duty Accreditation services, as well as discounts on Accreditation University ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of ... rating of “A” and its outlook as “stable.” At the same time, the ratings ... fallen in recent years, dip below “capital adequacy” thresholds required for its strong rating. ...
(Date:4/28/2017)... ... 28, 2017 , ... Ushio America proudly introduces the new ... energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts ... rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s ...
(Date:4/28/2017)... Texas (PRWEB) , ... April 28, 2017 , ... The ... plaque in recently to the labor and delivery team at Women’s Hospital at Renaissance ... mothers who give birth at the hospital and decide to donate. , “Women’s ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: